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Abstract 
Objective: Diterpene alkaloids are secondary plant metabolites and chemotaxonomical markers with a strong 
biological activity. These compounds are characteristic for the Ranunculaceae family, while their occurrence in other 
taxa is rare. Several species of the Spiraea genus (Rosaceae) are examples of this rarity. Screening Spiraea species for 
alkaloid content is a chemotaxonomical approach to clarify the classification and phylogeny of the genus. Novel phar‑
macological findings make further investigations of Spiraea diterpene alkaloids promising.
Results: Seven Spiraea species were screened for diterpene alkaloids. Phytochemical and pharmacological investiga‑
tions were performed on Spiraea chamaedryfolia, the species found to contain diterpene alkaloids. Its alkaloid‑rich 
fractions were found to exert a remarkable xanthine‑oxidase inhibitory activity and a moderate antibacterial activity. 
The alkaloid distribution within the root was clarified by microscopic techniques.
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Introduction
Plant metabolism, driven by photosynthesis, provides 
a huge number and a wide variety of natural products. 
These compounds are of great importance for their ben-
eficial biological activities in humans. The investigation 
for specific plant metabolites is also a useful tool for the 
clarification of taxonomical uncertainties.
Diterpene alkaloids are secondary metabolites belong-
ing to pseudoalkaloids [1]. This group of molecules 
includes numerous compounds with diverse skeletons 
and substitution patterns. These compounds can be clas-
sified according to the number of carbon atoms in the 
skeleton as bisnor-(C18), nor-(C19) and diterpene  (C20) 
alkaloids. Aconitum, Delphinium and Consolida genera 
(Ranunculaceae) are known to be characterized by the 
presence of diterpene alkaloids. Although such alkaloids 
have also been reported from some Inula (Asteraceae), 
Garrya (Garryaceae), Erythrophleum (Fabaceae) and 
Spiraea (Rosaceae) species [2, 3], the occurrence of dit-
erpene alkaloids in these taxa is sporadic. Since diterpene 
alkaloids are considered as chemotaxonomic markers [4], 
their presence in species other than those belonging to 
the Ranunculaceae family might have an important role 
in plant taxonomy.
The Spiraea genus, comprising approximately 100 spe-
cies, belongs to the Rosaceae family. Phytochemical con-
tents of 28 Spiraea taxa have been extensively studied. 
Mono-, di-, sesqui- and triterpenes have been isolated 
besides flavonoids, lignans, neolignans and other phenyl-
propane derivatives. Interestingly, only 9 of the investi-
gated taxa were found to contain diterpene alkaloids (S. 
formosana Hayata, S. fritschiana var. parvifolia Liou, S. 
japonica L.f., S. japonica var. acuta Yu, S. japonica var. 
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fortunei (Planchon) Rehder, S. japonica var. glabra (Regel) 
Koidz, S. japonica var. incisa Yu, S. japonica var. ovalifolia 
Zuo, S. japonica var. stellaris). All of the reported 65 dit-
erpene alkaloids bear hetisine- and atisine-type  C20 basic 
skeletons (Additional file 1: Spiraea diterpene alkaloids). 
Although only marginal ethnomedicinal use of Spiraea 
species has been documented in North-America and 
Asia, pharmacological studies have reported noteworthy 
activities of Spiraea extracts and isolated compounds [5].
The recent classification and clarification of Spiraea 
phylogeny is based mainly on molecular analyses [6–9]. 
The phytochemical analysis is also considered as a useful 
tool to support plant classification.
Phytochemical studies on Spiraea genus are promis-
ing, because of their possible utilization as source of 
pharmacons. On the other hand, screening of this genus 
for diterpene alkaloid content may contribute to the 
clarification of Spiraea phylogeny. These considerations 
motivated our research, aiming to improve the current 
phytochemical knowledge on Spiraea species.
Main text
Materials and methods
Plant material
Seven Spiraea species were analysed. S. crenata L. 
(SZTE-FG 850) and S. salicifolia L. (SZTE-FG 851) 
were collected and identified by Gusztáv Jakab (Szent 
István University, Budapest, Hungary) in Hungary 
(Sepsibükszád and Alsórákos, Hungary). S. nipponica 
Maxim (SZTE-FG 852), S. x vanhouttei (Briot) Zabel 
(SZTE-FG 853) and S. x billardii hort. ex K. Koch (SZTE-
FG 854) were collected and identified by Anikó Németh 
(Botanical Garden of University of Szeged, Szeged, Hun-
gary). S. media Schmidt. (DAU 0 31 147 009) and Spiraea 
chamaedryfolia L. (DAU 0 31 145 023) were harvested 
in Daugavpils (Latvia), and identification was performed 
by Santa Rutkovska (University of Daugavpils, Latvia). 
Voucher specimens were deposited at the herbarium of 
the Department of Pharmacognosy of the University of 
Szeged and at that of the University of Daugavpils. Herb 
and root of the plant material were separated, dried and 
stored at room temperature until processing.
Extraction and identification of the alkaloid content
Dried and crushed herb materials were extracted conse-
quently with methanol (MeOH), chloroform  (CHCl3) and 
2% aqueous HCl, by ultrasonication at room temperature 
(Fig.  1). The applied drug-solvent ratio was 1:5 in each 
case. The drug was dried before each extraction phase. 
Moistening with 5% aqueous NaOH solvent was applied 
prior to extraction with chloroform.
The methanol extract was acidified with 2% aque-
ous HCl and was then extracted with chloroform. Frac-
tion M1 was obtained by collecting and evaporating the 
organic phase. The pH of the aqueous phase was ren-
dered to alkaline (pH 12) with 5% aqueous NaOH and 
Fig. 1 Alkaloid contents and pharmacological activities of S. chamaedryfolia fractions
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was then extracted with chloroform. The chloroform 
phase yielded fraction M2.
The chloroform extract was further extracted with 
2% aqueous HCl. The organic phase was evaporated 
and used as fraction L1. The pH of the aqueous phase 
was made alkaline and extracted with chloroform. The 
organic phase was evaporated to yield fraction L2.
The acidic extract was subjected to solvent–solvent 
partitioning with chloroform, after adjusting the pH 
to alkaline. The dry residue of the organic phase was 
labelled as S1. The pH of the aqueous phase was rendered 
to acidic with 2% aqueous HCl and was then extracted 
with chloroform. The organic phase was evaporated to 
produce fraction S2.
Fractions were screened for alkaloid content by thin 
layer chromatography (TLC), carried out at room tem-
perature on silica gel  (SiO2 60 F254, Merck 1.05554.0001) 
and toluene/acetone/ethanol/cc.NH3 70:50:18:4.5 was 
applied as mobile phase. Detection was performed in two 
steps: (1) dry plates were sprayed with Dragendorff’s rea-
gent; and (2) after drying, the plates were sprayed again 
with 5% aqueous  NaNO2. The alkaloids appeared as per-
manent brown spots.
Screening for antibacterial activity
Plant extracts were tested for antibacterial activity 
using the following microorganisms as test strains in 
the screening assays: 3 different Gram-positive strains, 
namely Bacillus subtilis (ATCC 6633), Staphylococcus 
aureus (ATCC 29213), and Streptococcus pneumoniae 
(ATCC 49619) plus one Gram-negative strain, namely 
Moraxella catarrhalis (ATCC 25238). In addition, the 
multi-resistant strain, methicillin-resistant S. aureus 
(MRSA, ATCC 43300) was used to test whether the frac-
tions have a specific antibacterial effect on a strain of 
high public health priority. The test organisms were cul-
tured on standard Mueller–Hinton agar plates or Colum-
bia agar  +  5% sheep blood (COS) plates (bioMérieux) 
at 37 °C. The bacterial cultures were maintained in their 
appropriate plates at 4 °C throughout the experiment and 
were used as stock cultures.
Antibacterial activities of our plant extracts were evalu-
ated by the disc-diffusion method. The bacterial isolates 
for screening assay were prepared by picking single col-
ony from 24 h old plates and it was suspended in sterile, 
isotonic saline solution (5  mL) to reach 0.5 McFarland 
standard of optical turbidity, resulting in a suspension 
containing approximately 1–2 × 108 CFU/mL. The bac-
terial suspension was spread on appropriate sterile plates 
using a sterile cotton swab. Sterile filter paper discs 
(6 mm of diameter) were loaded with the extracts, using 
20 μL of dried extracts redissolved in a mixture of ethanol 
and water (40/60 v/v) at a concentration of 50  mg/mL. 
After drying, these loaded filter paper discs were placed 
on the plates containing the bacterial suspensions. Paper 
discs impregnated with 20 µL of pure solvent were used 
as a negative control. The plates were then incubated at 
37  °C for 24  h under aerobic conditions. Diameters of 
the inhibition zones produced by the plant extracts were 
measured and recorded (as the diameter of the inhibition 
zone plus the diameter of the disc) at 24 h.
Xanthine oxidase assay
The method is based on a continuous spectrophotomet-
ric rate determination: the absorbance of xanthine oxi-
dase (XO) enzyme induced uric acid production from 
xanthine was measured at 290 nm for 3 min. The enzyme-
inhibitory effect of our plant extracts was determined on 
the basis of the decrease in uric acid production. Rea-
gents used included: 50  mM potassium buffer, pH 7.5 
with 1 M KOH, 0.15 mM xanthine solution, pH 7.5, pre-
pared using xanthine, XO enzyme solution 0.2 Units/mL 
prepared using XO. The test solutions applied included: 
S. chamaedryfolia fractions 12 g/mL, 600 µg/mL diluted 
in DMSO solution. The final reaction mixture of 300 µL 
well contained: 100 µL xanthine, 150 µL buffer and 50 µL 
XO for enzyme-activity. Allopurinol was dissolved in 
DMSO and used as positive control (100% inhibition was 
considered at 10  μg/mL concentration of allopurinol). 
The reaction mixture for inhibition: 100  µL xanthine, 
140 µL buffer, 10 µL test and 50 µL XO.
Microscopical analysis
Specimens of the plant material were softened by ultra-
sonication in hot water for 1  h. Unembedded material 
was sectioned on a sledge microtome producing sections 
of 100  μm thickness. Observations were carried out on 
unstained sections. For histological characterisation 1% 
aqueous toluidine blue was used, and Dragendorff’s rea-
gent was applied for alkaloid localisation. Transverse sec-
tions were mounted with water/glycerol 1:1. The sections 
were observed under light microscope and photographic 
images were captured using a digital camera.
Results
Phytochemical screening revealed alkaloid content in S. 
chamaedryfolia roots, while all the other six Spiraea spe-
cies were alkaloid-free. The solvent–solvent partitioning 
of methanolic, acidic and alkaline extracts of S. chamae-
dryfolia yielded alkaloid-rich ethyl acetate (EtOAc), chlo-
roform and methanol fractions (Fig. 1). The most apolar 
fraction prepared with n-hexane (hex) was alkaloid-free. 
The attempt to isolate diterpene alkaloids have failed due 
to the low stability of the compounds.
The fractions were screened for in  vitro antibacterial 
and xanthine oxidase inhibitory activity. The ethyl acetate 
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fraction was found to be the most potent xanthine oxi-
dase inhibitor, exerting over 70% of inhibition compared 
to allopurinol (Fig. 1 and Table 1).
Three fractions were found to exert antibacterial activ-
ity against S. aureus (ATCC 29213), B. subtilis (ATCC 
6633), S. pneumoniae (ATCC 49619), and M. catarrhalis 
(ATCC 25238), while one fraction exerted antibacterial 
activity against methicillin-resistant S. aureus (MRSA) 
(ATCC 43300) (Fig. 1 and Table 1).
Examining the transverse section of the root of S. 
chamaedryfolia, structures characteristic of second-
ary root were observed (Fig.  2). The periderm, primary 
and secondary cortex, and xylems with medullary rays 
could be observed in the unstained sections. Primary 
and secondary cortex with fibers in the primary cortex 
became visible after staining with toluidine blue. Dragen-
dorff’s reagent revealed the presence of alkaloids in the 
secondary cortex and secondary xylem, while in the pith 
no signs of alkaloid content was observed.
Discussion
Plants may contain alkaloids in two forms: either as free 
base or as salts of organic acids. The compounds pre-
sent in the free base form can be extracted with organic 
solvents, while those in the salt form can be extracted 
using diluted inorganic acids. Diterpene alkaloids, and 
especially esters, may be unstable, thus they require 
special handling. For this reason alcoholic extraction is 
considered to be the most cautious method. However, 
the diverse structure and the substitution pattern of dit-
erpene alkaloid molecules might require acidic and alka-
line extraction as well. According to the literature, only 
alcoholic extraction was applied in previous phytochemi-
cal screening studies of Spiraea species, which might 
Table 1 Antibacterial and xanthine oxidase inhibitory activities of S. chamaedryfolia fractions
Fractions with activity (●) and fractions with no activity (○). (EtOAc ethyl acetate, MeOH methanol)
Fractions Bacillus 
subtilis
Staphylococcus 
aureus
Streptococcus pneu-
moniae
Moraxella catarrhalis Staphylococcus aureus 
MRSA
XO inhibition %
M1‑EtOAc ● ● ● ● ● ●
L1‑MeOH ○ ○ ○ ● ○ ○
L1‑EtOAc ○ ○ ○ ○ ○ ●
S2‑EtOAc ● ● ● ● ● ●
Fig. 2 Transverse section of the root of S. chamaedryfolia. Transverse sections of the secondary root of Spiraea chamaedryfolia, unstained (I), stained 
with 1% toluidine blue (II) and treated with Dragendorff reagent (III). (P periderm, C cortex, PC primary cortex, SC secondary cortex, X xylem, SX 
secondary xylem, MR medullary ray)
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have resulted in an incomplete extraction. To prevent 
the decomposition of the alkaloid content, the order of 
extraction was determined to be started by methanol, 
and followed by organic and acidic extraction steps. The 
application of all these three extraction methods yielded 
fractions with a diverse alkaloid profile.
Unfortunately, although 4.0 kg of dried roots was used 
for the preparative phytochemical work, our efforts to 
isolate pure alkaloids were unsuccessful. After purifica-
tion with adsorption chromatography (i.e. column chro-
matography and centrifugal planar chromatography) 
and gel filtration chromatography, the polarity and the 
molecular size of alkaloids and matrix compounds were 
similar within the obtained fractions, rendering separa-
tion impossible. Beside the notable amount of matrix 
compounds the highly unstable manner of alkaloids was 
also an obstacle to isolate pure compounds.
Fractions of S. chamaedryfolia were found to exert 
noteworthy biological activities. Xanthine oxidase 
inhibitory activity of S. chamaedryfolia fractions was 
remarkable, and the fractions also exerted a moderate 
antibacterial activity.
Proving the presence of alkaloids in S. chamaedryfolia 
is noteworthy, since only few taxa are known to have the 
ability to produce diterpene alkaloids: it has previously 
been reported for S. japonica 64 [10–29], S. fritchiana 2 
[12, 16], S. koreana [30] and S. formosa 1 [31] only. No 
other types of alkaloids have been reported for the Spi-
raea genus. The alkaloid content of S. chamaedryfolia 
and the lack of alkaloids for S. crenata, S. media, S. salici-
folia, S. nipponica, S. x vanhouttei and S. x billardii is first 
reported by our research group, making our phytochemi-
cal analyses pioneering in this field.
Limitations
Only TLC detection methods were applied to confirm 
the alkaloid content, the subtypes of these alkaloids was 
not elucidated by LC–MS or NMR techniques. However, 
since no other alkaloid types have been reported from 
the Spiraea genus, this finding suggests the presence 
(or absence) of diterpene alkaloids in the investigated 
species.
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